Bent Frandsen

Verkställande Direktör på EXPRES2ION BIOTECH HOLDING AB

Health Technology

Consumer Services

Profil

Bent U.
Frandsen currently works at ExpreS2ion Biotechnologies ApS, as Chief Executive Officer and Expres2ion Biotech Holding AB, as Chief Executive Officer from 2019.
Mr. Frandsen also formerly worked at Adaptvac ApS, as Director and NsGene A, as Vice President-Business Development.
Mr. Frandsen received his graduate degree in 1993 from Copenhagen Business School.

Aktiva positioner av Bent Frandsen

Företag	Position	Start
EXPRES2ION BIOTECH HOLDING AB	Verkställande Direktör	2019-12-20
ExpreS2ion Biotechnologies ApS ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology Operates as a biotech company which engages in the field of protein production in Drosophila Schneider-2 cells	Verkställande Direktör	-

Alla aktiva positioner av Bent Frandsen

Tidigare kända positioner av Bent Frandsen

Företag	Position	Slut
NsGene A/S NsGene A/S Pharmaceuticals: MajorHealth Technology Provides therapeutic products for the treatment of neurodegenerative disorders	Företagsledare/Principal	-
Adaptvac ApS Adaptvac ApS BiotechnologyHealth Technology Develops therapeutic and prophylactic vaccines	Direktör/Styrelseledamot	-

Se detaljerna i Bent Frandsens erfarenhet

Bent Frandsens utbildningar

Erfarenheter
Innehade positioner

Aktiva

Inaktiva

Börsnoterade företag

Privata företag

Se detaljerna i Bent Frandsens erfarenhet

Relationer

Första gradens relationer

Företag kopplade till första graden

Man

Kvinna

Styrelseledamöter

Chefer

Se det personliga nätverket

Kopplade företag

Privata företag	5
Copenhagen Business School Copenhagen Business School Other Consumer ServicesConsumer Services Functions as a College/University	Consumer Services
NsGene A/S NsGene A/S Pharmaceuticals: MajorHealth Technology Provides therapeutic products for the treatment of neurodegenerative disorders	Health Technology
ExpreS2ion Biotechnologies ApS ExpreS2ion Biotechnologies ApS BiotechnologyHealth Technology Operates as a biotech company which engages in the field of protein production in Drosophila Schneider-2 cells	Health Technology
Expres2ion Biotech Holding AB Expres2ion Biotech Holding AB BiotechnologyHealth Technology Engages in the development of a portfolio of vaccines for diseases such as COVID-19, influenza, and breast cancer	Health Technology
Adaptvac ApS Adaptvac ApS BiotechnologyHealth Technology Develops therapeutic and prophylactic vaccines	Health Technology